Erythritol is 6070% as sweet as sucrose -table sugar- yet it is almost noncaloric, does not affect blood sugar, does not cause tooth decay, and is partially absorbed by the body, excreted in urine and feces
In 2024, approximately 1/3 of the GLP-1 prescription volume was filled by compounders
Semaglutide portfolio pattern Semaglutide portfolios tend to include: long-acting formulation approaches that maintain stability and controlled release, dosing regimens (e.g., once-weekly), method-of-treatment claims for obesity and diabetes subpopulations
When shopping for food, these users were highly influenced by packaging claims such as, uses real ingredients," "high source of protein (or fiber), preservative-free, and natural flavor. (3) Most users are happy with the results they achieve, and 60% of those surveyed plan to use a GLP-1 medication regularly for the foreseeable future (more than one year)